Medical Devices & Consumables

Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Chronic Pain Extracorporeal Shock Wave Therapy Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Chattanooga
BTL Corporate
EMS DolorClast
Zimmer MedizinSysteme
Dornier MedTech
ASTAR
Richard Wolf
Gymna
Likamed GmbH
Inceler Medikal
Storz Medical
Segment by Type
Portable ESWT Devices
Tabletop ESWT Devices
Segment by Application
Orthopedics
Urology
Dermatology
Veterinary Medicine
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Chronic Pain Extracorporeal Shock Wave Therapy Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Chronic Pain Extracorporeal Shock Wave Therapy Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Portable ESWT Devices
1.2.3 Tabletop ESWT Devices
1.3 Market Segmentation by Application
1.3.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Orthopedics
1.3.3 Urology
1.3.4 Dermatology
1.3.5 Veterinary Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Estimates and Forecasts 2020-2031
2.4 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Portable ESWT Devices Market Size by Manufacturers
3.5.2 Tabletop ESWT Devices Market Size by Manufacturers
3.6 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Type (2020-2031)
6.4 North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Type (2020-2031)
7.4 Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chattanooga
11.1.1 Chattanooga Corporation Information
11.1.2 Chattanooga Business Overview
11.1.3 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.1.4 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Product in 2024
11.1.6 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application in 2024
11.1.7 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Geographic Area in 2024
11.1.8 Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
11.1.9 Chattanooga Recent Developments
11.2 BTL Corporate
11.2.1 BTL Corporate Corporation Information
11.2.2 BTL Corporate Business Overview
11.2.3 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.2.4 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Product in 2024
11.2.6 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application in 2024
11.2.7 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Geographic Area in 2024
11.2.8 BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
11.2.9 BTL Corporate Recent Developments
11.3 EMS DolorClast
11.3.1 EMS DolorClast Corporation Information
11.3.2 EMS DolorClast Business Overview
11.3.3 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.3.4 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Product in 2024
11.3.6 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application in 2024
11.3.7 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Geographic Area in 2024
11.3.8 EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
11.3.9 EMS DolorClast Recent Developments
11.4 Zimmer MedizinSysteme
11.4.1 Zimmer MedizinSysteme Corporation Information
11.4.2 Zimmer MedizinSysteme Business Overview
11.4.3 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.4.4 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Product in 2024
11.4.6 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application in 2024
11.4.7 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Geographic Area in 2024
11.4.8 Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
11.4.9 Zimmer MedizinSysteme Recent Developments
11.5 Dornier MedTech
11.5.1 Dornier MedTech Corporation Information
11.5.2 Dornier MedTech Business Overview
11.5.3 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.5.4 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Product in 2024
11.5.6 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application in 2024
11.5.7 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Geographic Area in 2024
11.5.8 Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
11.5.9 Dornier MedTech Recent Developments
11.6 ASTAR
11.6.1 ASTAR Corporation Information
11.6.2 ASTAR Business Overview
11.6.3 ASTAR Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.6.4 ASTAR Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ASTAR Recent Developments
11.7 Richard Wolf
11.7.1 Richard Wolf Corporation Information
11.7.2 Richard Wolf Business Overview
11.7.3 Richard Wolf Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.7.4 Richard Wolf Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Richard Wolf Recent Developments
11.8 Gymna
11.8.1 Gymna Corporation Information
11.8.2 Gymna Business Overview
11.8.3 Gymna Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.8.4 Gymna Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Gymna Recent Developments
11.9 Likamed GmbH
11.9.1 Likamed GmbH Corporation Information
11.9.2 Likamed GmbH Business Overview
11.9.3 Likamed GmbH Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.9.4 Likamed GmbH Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Likamed GmbH Recent Developments
11.10 Inceler Medikal
11.10.1 Inceler Medikal Corporation Information
11.10.2 Inceler Medikal Business Overview
11.10.3 Inceler Medikal Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.10.4 Inceler Medikal Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Inceler Medikal Recent Developments
11.11 Storz Medical
11.11.1 Storz Medical Corporation Information
11.11.2 Storz Medical Business Overview
11.11.3 Storz Medical Chronic Pain Extracorporeal Shock Wave Therapy Device Product Models, Descriptions and Specifications
11.11.4 Storz Medical Chronic Pain Extracorporeal Shock Wave Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Storz Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Chronic Pain Extracorporeal Shock Wave Therapy Device Industry Chain
12.2 Chronic Pain Extracorporeal Shock Wave Therapy Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Chronic Pain Extracorporeal Shock Wave Therapy Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Chronic Pain Extracorporeal Shock Wave Therapy Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Chronic Pain Extracorporeal Shock Wave Therapy Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Region (2020-2025) & (K Units)
Table 8. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Share by Manufacturers (2020-2025)
Table 12. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Chronic Pain Extracorporeal Shock Wave Therapy Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Extracorporeal Shock Wave Therapy Device as of 2024)
Table 16. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Manufacturing Base and Headquarters
Table 19. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Type (2020-2025) & (K Units)
Table 23. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Type (2026-2031) & (K Units)
Table 24. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Chronic Pain Extracorporeal Shock Wave Therapy Device ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application (2020-2025) & (K Units)
Table 29. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales by Application (2026-2031) & (K Units)
Table 30. Chronic Pain Extracorporeal Shock Wave Therapy Device High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Chronic Pain Extracorporeal Shock Wave Therapy Device ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Growth Accelerators and Market Barriers
Table 37. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Growth Accelerators and Market Barriers
Table 40. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Growth Accelerators and Market Barriers
Table 45. Southeast Asia Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Investment Opportunities and Key Challenges
Table 47. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Chattanooga Corporation Information
Table 51. Chattanooga Description and Major Businesses
Table 52. Chattanooga Product Models, Descriptions and Specifications
Table 53. Chattanooga Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Chattanooga Sales Value Proportion by Product in 2024
Table 55. Chattanooga Sales Value Proportion by Application in 2024
Table 56. Chattanooga Sales Value Proportion by Geographic Area in 2024
Table 57. Chattanooga Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
Table 58. Chattanooga Recent Developments
Table 59. BTL Corporate Corporation Information
Table 60. BTL Corporate Description and Major Businesses
Table 61. BTL Corporate Product Models, Descriptions and Specifications
Table 62. BTL Corporate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. BTL Corporate Sales Value Proportion by Product in 2024
Table 64. BTL Corporate Sales Value Proportion by Application in 2024
Table 65. BTL Corporate Sales Value Proportion by Geographic Area in 2024
Table 66. BTL Corporate Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
Table 67. BTL Corporate Recent Developments
Table 68. EMS DolorClast Corporation Information
Table 69. EMS DolorClast Description and Major Businesses
Table 70. EMS DolorClast Product Models, Descriptions and Specifications
Table 71. EMS DolorClast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. EMS DolorClast Sales Value Proportion by Product in 2024
Table 73. EMS DolorClast Sales Value Proportion by Application in 2024
Table 74. EMS DolorClast Sales Value Proportion by Geographic Area in 2024
Table 75. EMS DolorClast Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
Table 76. EMS DolorClast Recent Developments
Table 77. Zimmer MedizinSysteme Corporation Information
Table 78. Zimmer MedizinSysteme Description and Major Businesses
Table 79. Zimmer MedizinSysteme Product Models, Descriptions and Specifications
Table 80. Zimmer MedizinSysteme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Zimmer MedizinSysteme Sales Value Proportion by Product in 2024
Table 82. Zimmer MedizinSysteme Sales Value Proportion by Application in 2024
Table 83. Zimmer MedizinSysteme Sales Value Proportion by Geographic Area in 2024
Table 84. Zimmer MedizinSysteme Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
Table 85. Zimmer MedizinSysteme Recent Developments
Table 86. Dornier MedTech Corporation Information
Table 87. Dornier MedTech Description and Major Businesses
Table 88. Dornier MedTech Product Models, Descriptions and Specifications
Table 89. Dornier MedTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Dornier MedTech Sales Value Proportion by Product in 2024
Table 91. Dornier MedTech Sales Value Proportion by Application in 2024
Table 92. Dornier MedTech Sales Value Proportion by Geographic Area in 2024
Table 93. Dornier MedTech Chronic Pain Extracorporeal Shock Wave Therapy Device SWOT Analysis
Table 94. Dornier MedTech Recent Developments
Table 95. ASTAR Corporation Information
Table 96. ASTAR Description and Major Businesses
Table 97. ASTAR Product Models, Descriptions and Specifications
Table 98. ASTAR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. ASTAR Recent Developments
Table 100. Richard Wolf Corporation Information
Table 101. Richard Wolf Description and Major Businesses
Table 102. Richard Wolf Product Models, Descriptions and Specifications
Table 103. Richard Wolf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Richard Wolf Recent Developments
Table 105. Gymna Corporation Information
Table 106. Gymna Description and Major Businesses
Table 107. Gymna Product Models, Descriptions and Specifications
Table 108. Gymna Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Gymna Recent Developments
Table 110. Likamed GmbH Corporation Information
Table 111. Likamed GmbH Description and Major Businesses
Table 112. Likamed GmbH Product Models, Descriptions and Specifications
Table 113. Likamed GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Likamed GmbH Recent Developments
Table 115. Inceler Medikal Corporation Information
Table 116. Inceler Medikal Description and Major Businesses
Table 117. Inceler Medikal Product Models, Descriptions and Specifications
Table 118. Inceler Medikal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Inceler Medikal Recent Developments
Table 120. Storz Medical Corporation Information
Table 121. Storz Medical Description and Major Businesses
Table 122. Storz Medical Product Models, Descriptions and Specifications
Table 123. Storz Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Storz Medical Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources


List of Figures
Figure 1. Chronic Pain Extracorporeal Shock Wave Therapy Device Product Picture
Figure 2. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Portable ESWT Devices Product Picture
Figure 4. Tabletop ESWT Devices Product Picture
Figure 5. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Orthopedics
Figure 7. Urology
Figure 8. Dermatology
Figure 9. Veterinary Medicine
Figure 10. Others
Figure 11. Chronic Pain Extracorporeal Shock Wave Therapy Device Report Years Considered
Figure 12. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 14. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Market Share by Region (2020-2031)
Figure 16. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales (2020-2031) & (K Units)
Figure 17. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume Market Share in 2024
Figure 20. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Portable ESWT Devices Revenue Market Share by Manufacturer in 2024
Figure 23. Tabletop ESWT Devices Revenue Market Share by Manufacturer in 2024
Figure 24. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Market Share by Type (2020-2031)
Figure 25. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Market Share by Type (2020-2031)
Figure 26. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Market Share by Application (2020-2031)
Figure 27. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue Market Share by Application (2020-2031)
Figure 28. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales YoY (2020-2031) & (K Units)
Figure 29. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) in 2024
Figure 31. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) in 2024
Figure 41. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 46. France Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 61. India Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Chronic Pain Extracorporeal Shock Wave Therapy Device Revenue (2020-2025) & (US$ Million)
Figure 82. Chronic Pain Extracorporeal Shock Wave Therapy Device Industry Chain Mapping
Figure 83. Regional Chronic Pain Extracorporeal Shock Wave Therapy Device Manufacturing Base Distribution (%)
Figure 84. Global Chronic Pain Extracorporeal Shock Wave Therapy Device Production Market Share by Region (2020-2031)
Figure 85. Chronic Pain Extracorporeal Shock Wave Therapy Device Production Process
Figure 86. Regional Chronic Pain Extracorporeal Shock Wave Therapy Device Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies